Acceleration of cutaneous T-cell lymphoma following dupilumab administration
暂无分享，去创建一个
[1] S. Dusza,et al. Outcomes and Prognostic Factors In African American / Black Patients With Mycosis Fungoides And Sézary Syndrome: Retrospective Analysis Of 157 Patients From A Referral Cancer Center. , 2020, Journal of the American Academy of Dermatology.
[2] J. Silverberg,et al. Progression of Cutaneous T-Cell Lymphoma after dupilumab: Case review of 7 patients. , 2020, Journal of the American Academy of Dermatology.
[3] T. Chiba,et al. Diagnosis of Mycosis Fungoides Following Administration of Dupilumab for Misdiagnosed Atopic Dermatitis. , 2019, Acta dermato-venereologica.
[4] Y. Tao,et al. Racial disparity in mycosis fungoides: An analysis of 4495 cases from the US National Cancer Database , 2017, Journal of the American Academy of Dermatology.
[5] D. Stolz,et al. Interleukin-13 is overexpressed in cutaneous T-cell lymphoma cells and regulates their proliferation. , 2015, Blood.
[6] P. Heald,et al. Cutaneous T-cell lymphoma in skin of color. , 2009, Journal of the American Academy of Dermatology.